Press releases | WebDisclosure

PRESS RELEASE

published on 07/11/2024 at 07:30, 1 year 9 months ago

DRONE VOLT annonce le lancement d'une augmentation de capital ouverte à tous avec maintien du droit préférentiel de souscription
DRONE VOLT lance une augmentation de capital avec maintien du droit préférentiel de souscription, visant jusqu'à 2,6 millions d'euros, pour financer sa croissance. Opportunité d'investissement stratégique

Croissance Investissement Augmentation De Capital Droit Préférentiel De Souscription DRONE VOLT
PRESS RELEASE

published on 07/11/2024 at 07:30, 1 year 9 months ago

Inside Information / Other news releases
GenSight Biologics launches a newsletter for retail investors providing updates, news articles, conferences, and financial figures in French, available via subscription on the company's website

Subscription Retail Investors Newsletter French GenSight Biologics
PRESS RELEASE

published on 07/11/2024 at 07:30, 1 year 9 months ago

Informations privilégiées / Autres communiqués
GenSight Biologics lance une lettre d'information destinée aux investisseurs particuliers en France, présentant des actualités et des informations sur la société et ses projets innovants

Investisseurs Particuliers GenSight Biologics Thérapies Géniques Maladies Neurodégénératives Lettre D'information
PRESS RELEASE

published on 07/11/2024 at 07:29, 1 year 9 months ago

Fielmann Group grows HY1/2024 sales +12% over 2023, improves profitability
Fielmann Group reports 12% sales growth in HY1/2024, with improved profitability and outlook for Vision 2025. Digitalization and international expansion drive growth

Profitability Digitalization Fielmann Group HY1/2024 Sales Vision 2025
PRESS RELEASE

published on 07/11/2024 at 07:15, 1 year 9 months ago

Inside Information / Other news releases
Eurofins provides update to key stakeholders on actions responding to Muddy Waters' reports and plans for related party transactions. Additionally, the company addresses cash accounting and corporate governance

Corporate Governance Muddy Waters Related Party Transactions Stakeholders Eurofins
PRESS RELEASE

published on 07/11/2024 at 07:05, 1 year 9 months ago

Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business
Heidelberg Pharma AG reports positive preliminary efficacy data for HDP-101 in multiple myeloma clinical trial. Key events include AACR Meeting presentation & FDA Orphan Drug Designation

Clinical Trial HDP-101 Heidelberg Pharma AG AACR Meeting FDA Orphan Drug Designation
REGULATED PRESS RELEASE

published on 07/11/2024 at 07:01, 1 year 9 months ago

Biophytis obtient l’autorisation IND de la FDA pour démarrer son étude OBA de phase 2 dans l’obésité
Biophytis obtient l'autorisation IND de la FDA pour lancer l'étude OBA de phase 2 dans l'obésité avec BIO101 (20-hydroxyecdysone), visant à améliorer la force musculaire. Le professeur Marc-André Cornier dirigera l'étude multicentrique aux Etats-Unis

Biophytis BIO101 Obésité Autorisation IND Étude OBA
REGULATED PRESS RELEASE

published on 07/11/2024 at 07:01, 1 year 9 months ago

Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
Biophytis obtains FDA approval to start phase 2 OBA study in obesity with BIO101 (20-hydroxyecdysone), focusing on muscle strength improvement. Study led by Prof. Marc-André Cornier to start mid-2024 in the USA

Biophytis FDA Approval Obesity Treatment BIO101 Phase 2 OBA Study
PRESS RELEASE

published on 07/11/2024 at 07:00, 1 year 9 months ago

Gerresheimer remains on track in 1st half year 2024
Gerresheimer remains on track with 1.7% revenue growth and 2.9% EBITDA increase in the 1st half of 2024. Plastics & Devices division shows good revenue growth and improved margin. Forecast for 2024 and 2025 confirmed

EBITDA Revenue Growth Forecast Gerresheimer 1st Half Year 2024
PRESS RELEASE

published on 07/11/2024 at 06:58, 1 year 9 months ago

DocMorris with accelerated and significant eRx growth in new customers, market share and revenue
DocMorris reports accelerated eRx growth in new customers, market share, and revenue, with significant progress in eRx business and expanding customer base

Revenue Market Share DocMorris ERx Growth CardLink

Published on 04/25/2026 at 03:10, 18 hours 19 minutes ago

BEACN Announces Financial Results for Year Ended December 31, 2025
Published on 04/24/2026 at 22:05, 23 hours 24 minutes ago

Critical Elements Mourns the Loss of Director Marc Simpson
Published on 04/24/2026 at 22:05, 23 hours 24 minutes ago

Critical Elements Pleure la perte de son administrateur Marc Simpson
Published on 04/24/2026 at 22:00, 23 hours 29 minutes ago

Kidoz Inc. to Present 2025 Results and Highlight Platform Expansion and Business Momentum
Published on 04/24/2026 at 15:00, 1 day 6 hours ago

Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes

View all ACCESSWIRE

Published on 04/25/2026 at 16:25, 5 hours 4 minutes ago

Leading a New Era of Family Mobility! CHERY TIGGO V, the 3-in-1 Family Vehicle, Debuts at AutoChina2026
Published on 04/24/2026 at 22:43, 22 hours 46 minutes ago

EQS-Adhoc: Marley Spoon Group SE: Closing of the financing transaction in connection with the financial restructuring of its German subsidiary Marley Spoon SE with increased financing amou
Published on 04/24/2026 at 22:05, 23 hours 24 minutes ago

Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
Published on 04/24/2026 at 18:30, 1 day 2 hours ago

EUROPLASMA: Tirage de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2M€
Published on 04/24/2026 at 18:12, 1 day 3 hours ago

EQS-Adhoc: clearvise AG reviews dividend proposal in line with its dividend strategy and postpones Annual General Meeting

View all EQS

Published on 04/25/2026 at 07:00, 14 hours 29 minutes ago

DLSI - Chiffre d'affaires 1er trimestre 2026
Published on 04/24/2026 at 18:48, 1 day 2 hours ago

Laboratoires Euromedis - Communiqué résultat 2025
Published on 04/24/2026 at 18:00, 1 day 3 hours ago

SMTPC - Communiqué sur la mise à disposition du Rapport annuel 2025
Published on 04/24/2026 at 17:45, 1 day 3 hours ago

Share buyback for cancellation
Published on 04/24/2026 at 17:45, 1 day 3 hours ago

Imerys-04-2026-information-share-capital-and-voting-rights-as-of-31-March-2026

View all LES ECHOS COMFI WIRE

News